XML 48 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

The following table summarizes the stock option activity during the year ended December 31, 2022 (in thousands, except number of shares, exercise prices and contractual term):

 

 

 

Number of shares

 

 

Weighted-average
exercise price

 

 

Weighted-average
remaining contractual
term (in years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2021

 

 

4,204,686

 

 

$

19.19

 

 

 

8.2

 

 

 

 

Granted

 

 

2,327,820

 

 

 

12.61

 

 

 

 

 

 

 

Exercised

 

 

(383,120

)

 

 

3.62

 

 

 

 

 

 

 

Forfeited

 

 

(630,111

)

 

 

21.99

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

5,519,275

 

 

$

17.17

 

 

 

8.1

 

 

$

2,915

 

Exercisable at December 31, 2022

 

 

2,337,753

 

 

$

17.49

 

 

 

7.4

 

 

$

1,957

 

Vested and expected to vest at
   December 31, 2022

 

 

5,519,275

 

 

$

17.17

 

 

 

8.1

 

 

$

2,915

 

Summary of Additional Information Related to Stock Options

Additional information related to the Company’s stock options is summarized below (in thousands, except per share amounts):

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Weighted-average grant-date fair value of stock option grants per share

 

$

8.60

 

 

$

30.87

 

Intrinsic value of options exercised

 

$

4,268

 

 

$

9,991

 

Summary of Restricted Stock Unit Activity

The following table summarizes the restricted stock unit activity during the year ended December 31, 2022:

 

 

Number of shares

 

 

Weighted-average
grant date fair value per share

 

 

Weighted-
average
remaining
contractual
term
(in years)

 

Outstanding at December 31, 2021

 

 

 

 

$

 

 

 

 

Granted

 

 

389,388

 

 

 

12.62

 

 

 

 

Forfeited

 

 

(32,660

)

 

 

12.15

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

356,728

 

 

$

12.66

 

 

 

1.7

 

Summary of Common Stock Reserved For Future Issuance

As of December 31, 2022, the Company had reserved the following shares of common stock for future issuance:

 

 

 

December 31,
2022

 

Common stock options and restricted stock units granted and outstanding

 

 

5,876,003

 

Reserved for future equity award grants

 

 

1,775,102

 

Reserved for future ESPP issuances

 

 

890,770

 

 

 

 

8,541,875

 

Summary of Share-based Compensation Expense

Share-based compensation expense for the years ended December 31, 2022 and 2021 were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

Research and development

 

$

7,326

 

 

$

6,719

 

General and administrative

 

 

9,530

 

 

 

7,742

 

Total share-based compensation expense

 

$

16,856

 

 

$

14,461

 

Schedule of Fair Value of Stock Options Estimated on Date of Grant Using Black-Scholes Option Pricing Model

The fair value of stock options was estimated on the date of grant using the Black-Scholes option pricing model with the following range of assumptions:

 

 

 

Year Ended December 31,

 

 

2022

 

2021

Options

 

 

 

 

Common stock fair value

 

$5.99 - $18.44

 

$15.35 - $54.89

Risk-free interest rate

 

1.6% - 4.2%

 

0.6% - 1.4%

Expected volatility

 

75.7% - 78.9%

 

77.3% - 79.9%

Expected term (in years)

 

5.5 - 6.1

 

5.5 - 6.1

Expected dividend yield

 

 

ESPP

 

 

 

 

Risk-free interest rate

 

1.6% - 4.7%

 

Expected volatility

 

63.8% - 151.9%

 

Expected term (in years)

 

0.5

 

Expected dividend yield